In situ engineering of mRNA-CAR T cells using spleen-targeted ionizable lipid nanoparticles to eliminate cancer cells

已完结 10 由 Direction92 发布于 2025/6/17 22:16:47

DOI:10.1016/j.nantod.2024.102518
作者：Yuan Li , Yishi Tian , Chanjuan Li , Wenli Fang , Xiaohong Li , Zhangyan Jing , Zhaoxin Yang , Xiaozhou Zhang , Yanlan Huang , Jiaqi Gong , Fanqiang M
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Chimeric antigen receptor (CAR) T cell therapy has implemented impressive advances in the treatment of B-cell lymphoma. However, the complex production process of CAR T cells and hindrance o

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Elsevier“Positive” or “Threatened”? The impact of the features in generative artificial intelligence on continued behavior